In this study, our findings established the biological significance of parasympathetic activation, α7nAchR, Th17 cells, and IL17A as potential therapeutic targets for patients suffering from lung fibrosis-induced PH. This evidence concerns the gene CHRNA7 and pulmonary fibrosis.